28.01.2014 Views

C.I. Pigment Brown 24 CAS N°: 68186-90-3

C.I. Pigment Brown 24 CAS N°: 68186-90-3

C.I. Pigment Brown 24 CAS N°: 68186-90-3

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

OECD SIDS C.I. PIGMENT BROWN <strong>24</strong><br />

TOXICITY ID <strong>68186</strong>-<strong>90</strong>-3<br />

DATE: 26-NOV-2004<br />

5.0 Toxicokinetics, Metabolism and Distribution<br />

Type:<br />

Toxicokinetics<br />

Species:<br />

rat<br />

No. of animals, males: 5<br />

No. of animals, females: 5<br />

Doses, males: 10, 100, 1000, 10000 mg/kg diet (0.5, 5, 50, 500<br />

mg/kg bw/day)<br />

Doses, females: 10, 100, 1000, 10000 mg/kg diet (0.5, 5, 50, 500<br />

mg/kg bw/day)<br />

Route of administration: oral feed<br />

Exposure time:<br />

<strong>90</strong> day(s)<br />

Method: other:comparable to OECD guideline 408<br />

GLP:<br />

no data<br />

Remark:<br />

Result:<br />

The detected traces of antimony (see results) most likely<br />

originate from the acid-soluble impurities of the pigment<br />

(10-20 mg antimony/kg pigment, that is 5-10 microgram/kg bw or<br />

125-250 microgram/kg organ weights at the highest dose) and<br />

therefore do not indicate bioavailability of the pigment<br />

itself.<br />

TOXICICITY<br />

No deaths, no overt signs of reactions to the treatment, no<br />

effects on body weight gain (similar food consumption in all<br />

groups) or organ weight, no treatment related findings<br />

from haematological or biochemical investigations and<br />

urinalysis.<br />

No macroscopic pathological changes attributable to<br />

treatment. No treatment related effects observed in<br />

histopathology.<br />

CHEMICAL ANALYSIS<br />

Antimony<br />

In males and females the Sb concentrations in liver and<br />

kidney were below the detection limit at doses up to 1000<br />

ppm. In the high dose groups the Sb levels slightly<br />

increased with exposure duration and reached max. 27 ppb in<br />

the liver (3 mo) of males (range 15-40 ppb) and 17 ppb in<br />

females (kidney 14 ppb in males and 15 ppb in females).<br />

Chromium<br />

No measurable effect on chromium content of liver and kidney<br />

at any dose level and exposure duration.<br />

Test condition:<br />

AUTHORS CONCLUSION<br />

The bioavailable traces of metals are considered to have no<br />

toxicological significance.<br />

EXPERIMENTAL DESIGN<br />

15 animals per dose per gender for toxicological<br />

investigations and 30 animals per gender in the control<br />

group;<br />

additionally 10 animals per dose and gender for analytical<br />

investigations and 20 animals per gender in the control<br />

group.<br />

Tests started at the age of 4- 5 weeks; TS given in powdered<br />

food (Altromin); feed and tape water ad libitum.<br />

General observations:<br />

Rats observed daily; food consumption and body weight gain<br />

determined once per week.<br />

UNEP PUBLICATIONS 31

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!